Article Text

Download PDFPDF
Cutaneous leprosy in Central Florida man with significant armadillo exposure
  1. Christopher Michael Logas1 and
  2. Kathryn B Holloway2
  1. 1 Dermatology, Larkin Community Hospital, Hialeah, Florida, USA
  2. 2 Ocala Dermatology, Ocala, Florida, USA
  1. Correspondence to Dr Christopher Michael Logas, chlogas{at}


Leprosy is a chronic infectious, granulomatous disease caused by the intracellular bacillus Mycobacterium leprae that infects macrophages and Schwann cells. While relatively rare in the USA, there is about 200 new cases of leprosy every year with the majority occurring in the southern parts of the country. It is believed to be linked to the region of the nine-banned armadillo in patients with no significant travel history outside of the country. In this case report, we encountered a 58-year-old Central Florida man that had extensive exposure to armadillos and presented with the typical symptoms of large erythaematous patches, numbness and peripheral nerve hypertrophy. Once diagnosed properly, patients are then reported to the National Hansen’s Centre who provides the multidrug therapy for 12–24 months. Due to its rarity and its ability to mimic other more common ailments, leprosy should be included in the differential diagnosis in patients that have significant exposure to armadillos, live in the southern part of the country or have recently travelled to countries that have a high prevalence of leprosy.

  • dermatology
  • infections
  • skin
  • general practice/family medicine
  • dermatological

Statistics from


  • Contributors CML is the main author for the case write up, body of the article and research for this case. KBH: saw, diagnosed, treated and continues to follow-up patient’s progress. She also took the photographs of the lesion that are displayed in this article. She is responsible for gaining patient’s permission and waver for this case report.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.